BlackRock Inc. - MARKER THERAPEUTICS INC ownership

MARKER THERAPEUTICS INC's ticker is MRKR and the CUSIP is 57055L107. A total of 54 filers reported holding MARKER THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 0.19 and the average weighting 0.0%.

Quarter-by-quarter ownership
BlackRock Inc. ownership history of MARKER THERAPEUTICS INC
ValueSharesWeighting
Q4 2022$33,914
-21.1%
127,546
+8.5%
0.00%
Q3 2022$43,000
+7.5%
117,515
-2.8%
0.00%
Q2 2022$40,000
-65.2%
120,959
-53.9%
0.00%
Q1 2022$115,000
-54.9%
262,371
-2.2%
0.00%
Q4 2021$255,000
-41.8%
268,239
+3.5%
0.00%
Q3 2021$438,000
-39.3%
259,054
+0.2%
0.00%
Q2 2021$722,000
-84.5%
258,554
-87.5%
0.00%
Q1 2021$4,649,000
+55.2%
2,076,042
+0.5%
0.00%
Q4 2020$2,996,000
+1.7%
2,066,417
+5.3%
0.00%
Q3 2020$2,945,000
-27.8%
1,963,223
-0.4%
0.00%
Q2 2020$4,078,000
+12.5%
1,970,307
+3.3%
0.00%
Q1 2020$3,624,000
-34.7%
1,907,644
-1.0%
0.00%
Q4 2019$5,550,000
-40.8%
1,927,447
+5.0%
0.00%
Q3 2019$9,379,000
-33.5%
1,835,346
+3.1%
0.00%
-100.0%
Q2 2019$14,102,000
+1318.7%
1,780,753
+1083.0%
0.00%
Q1 2019$994,000
+837.7%
150,524
+689.2%
0.00%
Q4 2018$106,00019,0740.00%
Other shareholders
MARKER THERAPEUTICS INC shareholders Q1 2022
NameSharesValueWeighting ↓
Aisling Capital Management LP 3,142,857$2,986,0001.05%
ACT CAPITAL MANAGEMENT, LLC 354,400$337,0000.24%
NEA Management Company, LLC 10,714,285$10,179,0000.21%
Long Focus Capital Management, LLC 1,233,257$1,172,0000.16%
Mandatum Life Insurance Co Ltd 99,000$94,0000.02%
MATRIX ASSET ADVISORS INC/NY 150,000$143,0000.02%
AR ASSET MANAGEMENT INC 71,500$68,0000.02%
KENNEDY CAPITAL MANAGEMENT LLC 590,118$561,0000.01%
WealthTrust Axiom LLC 22,700$21,0000.01%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 324,216$308,0000.01%
View complete list of MARKER THERAPEUTICS INC shareholders